Photo by chrisjoelcampbell from unsplash
Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop… Click to show full abstract
Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.
Keywords:
gastric cancer;
face gastric;
cancer;
cancer epidemiologic;
changing face
Journal Title: Cancer gene therapy
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer gene therapy
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!